Market Cap

argenx SE Market Capitalization:

$26.22 Billion

USD as of July 1, 2024

business argenx SE Company Profile

argenx SE Main Stock Listing

NASDAQ: ARGX

Market Capitalization History of argenx SE

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of argenx SE market cap

Date Market Cap YoY Change
Jan. 1, 2024 $22.96 B 9.57%
Jan. 1, 2023 $20.96 B 38.03%
Jan. 1, 2022 $15.19 B -8.11%
Jan. 1, 2021 $16.53 B 103.08%
Jan. 1, 2020 $8.14 B 35.98%
Jan. 1, 2019 $5.98 B 36.77%
Jan. 1, 2018 $4.38 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

argenx SE Categories

Netherlands languages Healthcare languages Biotechnology
Netherlands Healthcare Netherlands Biotechnology

Stocks & Indices

argenx SE has the following listings and related stock indices.


Stock: NASDAQ: ARGX

Stock: Bovespa: A1RG34

Stock: FSX: 1AE

Stock: OTC: ARGNF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.